U.S. Mortgage REITs Stock News

If you are wondering whether Merit Medical Systems at around US$67.55 is starting to look appealing or still feels expensive, the recent share performance gives you a useful starting point. The stock has seen a 3.8% decline over the last 7 days, a 17.8% fall over the last 30 days, and is down 21.9% year to date and 35.5% over the past year, while the 5 year return stands at 13.4%. These moves have put more attention on how the market currently prices Merit Medical Systems and whether...

Hamilton Lane stock reacts as Credit Income Fund clears key SEC milestone Hamilton Lane (HLNE) is back in focus after the U.S. Securities and Exchange Commission declared its Hamilton Lane Credit Income Fund effective, opening the door for broader access to middle market senior loan exposure. See our latest analysis for Hamilton Lane. Despite the SEC milestone for its Credit Income Fund, Hamilton Lane’s recent share price momentum has been weak, with a 30-day share price return of 6.98% and a...

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings forecasted to grow by 16% annually. In this context of fluctuating performance, identifying small-cap stocks with potential insider buying can be an intriguing strategy for investors seeking opportunities that may not be immediately apparent in larger market trends.

ICON (NasdaqGS:ICLR) has drawn fresh attention after announcing a definitive partnership with Advarra to build a connected, research ready clinical trial site network that aims to simplify operations and widen trial access. See our latest analysis for ICON. Despite the Advarra agreement and recent conference appearances, ICON’s recent share price return has been mixed, with modest gains over the past month but a much weaker 90 day share price return of 44.9% and a 1 year total shareholder...

If you are wondering whether Capital One Financial at around US$184 per share still offers value, or if most of the opportunity is already reflected in the price, this article walks you through what the current valuation indicates about the stock. The share price has moved 0.7% over the past week, declined 11.4% over the last month and is down 25.5% year to date, while showing a 2.6% return over 1 year and 113.2% over 3 years. The recent pullback therefore sits against a much stronger...

Why Woodward is on investors’ radar today Woodward (WWD) is drawing attention after recent share price swings, with the stock up around 2% over the past day but down over the past month, prompting fresh interest in its valuation. See our latest analysis for Woodward. Beyond the latest 2.03% 1 day share price return, Woodward’s 90 day share price return of 17.56% and 1 year total shareholder return of 91.95% suggest momentum has been strong over both shorter and longer periods. If Woodward’s...

Over the last 7 days, the United States market has dropped 2.3%, but it has experienced a 13% rise over the past year, with earnings forecast to grow by 16% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability in an evolving market landscape.

Zillow Group (NasdaqGS:ZG) has entered a new multiyear partnership with Major League Baseball. The company will be the official real estate and home rentals marketplace partner across national broadcasts and in stadium integrations throughout the MLB season. Zillow Group, trading at a recent share price of $45.09, is tying its brand to one of the most widely watched sports leagues in the US. For investors following NasdaqGS:ZG, this move comes after a 31.3% decline year to date and a 37.4%...

Doppel Games has announced a collaboration with Kash to introduce real-time prediction markets for AI-driven battles in its Agent vs Agent (AvA) competitions, hosted on X (formerly Twitter). This partnership enables live, tradeable outcomes for these AI battles, creating a novel type of social-native entertainment. The matches, which feature AI doppelgangers of well-known personalities, are streamed live, allowing viewers to engage by predicting outcomes directly within their social media...

Event context for XPO XPO (XPO) recently drew investor interest after a period in which the stock showed a one-month return of about an 11% decline, even as its past three-month return stood near 32%. See our latest analysis for XPO. Recent trading has been choppy, with a 1 day share price return of 0.39% and a 30 day share price decline of 11.22%. However, the 90 day share price return of 32.02% and 1 year total shareholder return of 67.83% suggest that momentum has been stronger over the...

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it remains up by 13% over the past year with earnings projected to grow by 16% annually. In this context, identifying stocks that are trading below their intrinsic value can present opportunities for investors seeking to capitalize on potential long-term gains amidst fluctuating market conditions.

In March 2026, MBX Biosciences, Inc. reported wider net losses for the fourth quarter and full year 2025, while also filing multiple shelf registrations covering common stock, preferred stock, debt securities, warrants, and units. An interesting aspect of these filings is the US$78.01 million common stock shelf tied to an employee stock ownership plan, which highlights MBX Biosciences’ focus on equity-based incentives alongside broader capital-raising flexibility. Next, we will examine how...

Regeneron Pharmaceuticals and Sanofi recently received Japanese Ministry of Health, Labour and Welfare approval for Dupixent as the first targeted treatment for adults with moderate-to-severe bullous pemphigoid, based on pivotal LIBERTY-BP-ADEPT phase 2/3 data showing more than four times as many patients achieved sustained disease remission versus placebo at Week 36. This decision adds a seventh Dupixent indication in Japan, reinforcing the drug’s broad immunology footprint while addressing...

Why Southwest Airlines (LUV) Is Back on Investors’ Radar Southwest Airlines (LUV) has drawn fresh attention after recent trading, with the share price around $39.83 and a month return of about a 24% decline, prompting investors to reassess the carrier’s fundamentals and valuation. See our latest analysis for Southwest Airlines. The recent 1 month share price return of about a 24% decline sits in contrast to a 1 year total shareholder return of 17.2%, so recent momentum has cooled even though...

Vicor stock performance snapshot Vicor (VICR) has drawn attention after a strong past 3 months, with the share price up 66.4%, while the past month shows a more moderate 6.2% move and a 4.3% gain today. See our latest analysis for Vicor. The recent 1 day share price return of 4.29% and 30 day share price return of 6.17% sit against a much stronger 90 day share price return of 66.42% and a 1 year total shareholder return of 230.59%, which together point to strong momentum over both shorter and...

The recent 13% drop in Indaptus Therapeutics, Inc.'s ( NASDAQ:INDP ) stock could come as a blow to insiders who...

How General Dynamics Stock Has Been Performing General Dynamics (GD) has seen mixed share performance recently, with a 0.3% decline over the past day, a 2.8% pullback over the past week, and a modest 0.2% gain over the past 3 months. Over longer holding periods, the stock shows stronger total returns: 32% over the past year, 63% over 3 years, and 112% over 5 years, all measured on a total return basis. See our latest analysis for General Dynamics. Recent share price pressure, including a 2.8%...

AerCap Holdings N.V. recently announced it signed lease agreements with Ethiopian Airlines for two Boeing 777-300ERSF converted freighters, which will become the first of their type to operate in Africa when they are delivered in the second quarter of 2028. This move expands AerCap’s presence in the fast-growing dedicated cargo segment and highlights demand for higher-capacity, fuel-efficient freighters that can support airlines’ regional and long-haul freight ambitions. We’ll now examine...

Over the last 7 days, the United States market has dropped 2.3%, yet it has risen by 13% over the past year, with earnings forecasted to grow by 16% annually. In this context of fluctuating short-term performance and promising long-term growth prospects, stocks with high insider ownership can be particularly appealing as they often indicate confidence from those closest to the company's operations and future potential.

Sumitomo Mitsui Financial Group is reportedly exploring a potential takeover of Jefferies Financial Group, NYSE:JEF. Media reports indicate preliminary discussions and a gradual stake build since 2021, although no formal offer has been announced. Jefferies' management has publicly stated there are no active negotiations, keeping the situation in a speculative phase. For investors watching NYSE:JEF at a current share price of $40.55, the takeover speculation comes against a mixed performance...

Over the last 7 days, the U.S. market has dropped by 2.3%, though it has shown a robust increase of 13% over the past year, with earnings projected to grow by 16% annually in the coming years. In such fluctuating conditions, identifying stocks with strong fundamentals and solid balance sheets can be crucial for investors seeking growth opportunities at lower price points. Penny stocks, often representing smaller or newer companies, continue to present underappreciated potential for growth and...

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it remains up by 13% over the past year with earnings projected to grow by 16% annually. In this context, identifying stocks with strong fundamentals and growth potential can be key to uncovering promising opportunities in an evolving market landscape.

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it has shown resilience with a 13% rise over the past year and earnings are expected to grow by 16% annually. In such dynamic conditions, dividend stocks can offer investors stability and income potential, making them an attractive option for those seeking steady returns amidst market fluctuations.

Insiders who bought US$1.73m worth of Cartesian Therapeutics, Inc.'s ( NASDAQ:RNAC ) stock at an average buy price of...